[{"NetIncomeLoss_2_Q2_USD":-40595000.0,"GeneralAndAdministrativeExpense_2_Q2_USD":12629000.0,"GeneralAndAdministrativeExpense_1_Q2_USD":6491000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":72063881.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":73306248.0,"CommitmentsAndContingencies_0_Q2_USD":null,"InterestPaidNet_2_Q2_USD":1226000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":1000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0_Q2_USD":10144000.0,"PaymentsForRestructuring_2_Q2_USD":192000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":27088000.0,"PaymentsToAcquireInvestments_2_Q2_USD":12931000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2_Q2_shares":4324865.0,"AssetsCurrent_0_Q2_USD":72716000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_0_Q2_USD":11.91,"LongTermDebt_0_Q2_USD":25000000.0,"RestructuringCharges_2_Q2_USD":0.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":11618712.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q2_USD":15000.0,"CommonStockSharesIssued_0_Q2_shares":75131834.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q2_USD":2404000.0,"Assets_0_Q2_USD":100678000.0,"ShareBasedCompensation_2_Q2_USD":3873000.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":10257000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_2_Q2_USD":10.91,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.001,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.001,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_2_Q2_USD":2.17,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1_Q2_USD":2.41,"RestructuringCharges_1_Q2_USD":0.0,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_0_Q2_USD":12081000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q2_USD":11000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":41842000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":20099000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q2_USD":7.88,"RestrictedInvestmentsNoncurrent_0_Q2_USD":1400000.0,"ProceedsFromStockPlans_2_Q2_USD":249000.0,"AccountsReceivableNetCurrent_0_Q2_USD":2929000.0,"IncomeTaxExpenseBenefit_1_Q2_USD":0.0,"IncomeTaxExpenseBenefit_2_Q2_USD":0.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax_1_Q2_USD":11000.0,"CommonStockValue_0_Q2_USD":75000.0,"OtherNonoperatingIncome_2_Q2_USD":844000.0,"OtherNonoperatingIncome_1_Q2_USD":476000.0,"Revenues_2_Q2_USD":14234000.0,"Revenues_1_Q2_USD":6045000.0,"LongTermNotesPayable_0_Q2_USD":24863000.0,"DepreciationDepletionAndAmortization_2_Q2_USD":3493000.0,"DepreciationDepletionAndAmortization_1_Q2_USD":1691000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":19139000.0,"FairValueAssetsLevel2ToLevel1TransfersAmount_0_Q2_USD":0.0,"CashCashEquivalentsAndShortTermInvestments_0_Q2_USD":63940000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-40594000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-20703000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":-700000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":61536000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":13181000.0,"ProceedsFromSaleMaturityAndCollectionsOfInvestments_2_Q2_USD":40318000.0,"AdditionalPaidInCapitalCommonStock_0_Q2_USD":434593000.0,"Liabilities_0_Q2_USD":166253000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_2_Q2_USD":1000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":1928000.0,"IncomeTaxExaminationPenaltiesAndInterestAccrued_0_Q2_USD":0.0,"FairValueAssetsLevel1ToLevel2TransfersAmount_0_Q2_USD":0.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":10648000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":-3590000.0,"IncreaseDecreaseInAccountsReceivable_2_Q2_USD":1144000.0,"CommonStockSharesOutstanding_0_Q2_shares":75131834.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q2_USD":31235000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_2_Q2_USD":1000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q2_USD":11000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q2_USD":1000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":1914000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-49817000.0,"LiabilitiesCurrent_0_Q2_USD":44248000.0,"AccountsPayableCurrent_0_Q2_USD":4163000.0,"NonoperatingIncomeExpense_2_Q2_USD":-358000.0,"NonoperatingIncomeExpense_1_Q2_USD":-169000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-500244000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":61536000.0,"ProceedsFromStockOptionsExercised_2_Q2_USD":75000.0,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":890000.0,"InterestExpenseDebt_2_Q2_USD":1435000.0,"InterestExpenseDebt_1_Q2_USD":719000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_2_Q2_shares":141281.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_0_Q2_USD":949000.0,"PreferredStockSharesIssued_0_Q2_shares":0.0,"CapitalExpendituresIncurredButNotYetPaid_2_Q2_USD":66000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_2_Q2_USD":0.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_1_Q2_USD":0.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_0_Q2_USD":4670000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":16305000.0,"NetIncomeLoss_1_Q2_USD":-20714000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":5847000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0_Q2_shares":4983417.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q2_shares":11578482.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_2_Q2_USD":102000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":5186000.0,"OperatingIncomeLoss_2_Q2_USD":-40237000.0,"OperatingIncomeLoss_1_Q2_USD":-20545000.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q2_USD":2404000.0,"RestructuringReserve_0_Q2_USD":0.0,"InvestmentIncomeInterest_2_Q2_USD":233000.0,"InvestmentIncomeInterest_1_Q2_USD":74000.0,"ContractWithCustomerLiabilityCurrent_0_Q2_USD":5653000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_2_Q2_USD":3.52,"PreferredStockValue_0_Q2_USD":null,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_2_Q2_USD":0.48,"LiabilitiesAndStockholdersEquity_0_Q2_USD":100678000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":3451000.0,"PreferredStockSharesAuthorized_0_Q2_shares":10000000.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_0_Q2_USD":11970000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":3873000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":1914000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_2_Q2_shares":915785.0,"PropertyPlantAndEquipmentGross_0_Q2_USD":47540000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":4788000.0,"OperatingExpenses_2_Q2_USD":54471000.0,"OperatingExpenses_1_Q2_USD":26590000.0,"EarningsPerShareBasicAndDiluted_2_Q2_USD":-0.56,"EarningsPerShareBasicAndDiluted_1_Q2_USD":-0.28,"OtherLiabilitiesNoncurrent_0_Q2_USD":752000.0,"StockholdersEquity_0_Q2_USD":-65575000.0,"ContractWithCustomerLiabilityNoncurrent_0_Q2_USD":2826000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":299000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q2_USD":2403000.0,"CommonStockSharesAuthorized_0_Q2_shares":200000000.0,"IncreaseDecreaseInContractWithCustomerLiability_2_Q2_USD":-11837000.0,"Ticker":"MCRB","CIK":"1609809","name":"SERES THERAPEUTICS, INC.","OfficialName":"Seres Therapeutics Inc. Common Stock","form":"10-Q","period":"20200630","fy":"2020.0","fp":"Q2","qtrs":"2","uom":"USD","footnote":"nan","Market Cap":"533683334.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20200728"}]